Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...
What is cancer immunotherapy, how does it work, and why are people so excited about it?